JEANEAN AMING: Open Payments
NPI 1073957544 · WAPPINGERS FALLLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,651 in 45 payments from 14 companies in 2025. Trend: 2023 $1,419 · 2024 $1,519 · 2025 $1,651
Food & beverage: $1,651
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $309 |
| Alkermes, Inc. | 7 | $286 |
| Otsuka America Pharmaceutical, Inc. | 6 | $214 |
| Janssen Pharmaceuticals, Inc | 3 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $181 |
| Neurocrine BioSciences, Inc. | 4 | $171 |
| Axsome Therapeutics, Inc. | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Gilead Sciences, Inc. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
Products named: VRAYLAR, INVEGA SUSTENNA, CAPLYTA, REXULTI, INGREZZA, ARISTADA, LYBALVI, Auvelity.
Industry payments across NY — which companies pay providers there.
